NeuroPace, Inc.
NPCE
$10.79
$0.363.45%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -27.14M | -28.09M | -29.90M | -31.51M | -32.96M |
Total Depreciation and Amortization | 1.77M | 1.73M | 1.67M | 1.63M | 1.61M |
Total Amortization of Deferred Charges | 228.00K | 255.00K | 282.00K | 297.00K | 283.00K |
Total Other Non-Cash Items | 12.65M | 12.86M | 13.49M | 13.53M | 13.85M |
Change in Net Operating Assets | -5.45M | -3.25M | -2.62M | -1.49M | -2.48M |
Cash from Operations | -17.95M | -16.49M | -17.07M | -17.53M | -19.70M |
Capital Expenditure | -306.00K | -299.00K | -208.00K | -145.00K | -173.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 9.30M | 10.80M | 13.50M | 15.50M | 23.20M |
Cash from Investing | 8.99M | 10.50M | 13.29M | 15.36M | 23.03M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 5.21M | 12.71M | 9.75M | 9.41M | 8.69M |
Repurchase of Common Stock | -881.00K | -826.00K | -793.00K | -762.00K | -259.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -186.00K | -186.00K | -195.00K | -305.00K |
Cash from Financing | 4.33M | 11.69M | 8.77M | 8.45M | 8.13M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -4.63M | 5.70M | 4.99M | 6.28M | 11.45M |